August, M; Wingerter, O; Oelze, M et al.
Mechanisms underlying dysfunction of carotid arteries in genetically hyperlipidemic rabbits.Nitric Oxide. Bd. 15. H. 3. 2006 S. 241-251
Peetz, D; Schweigert, R; Jachmann, N et al.
Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.Clin Lab. Bd. 52. H. 11-12. 2006 S. 605-14
Mollnau, H; Wenzel, P; Oelze, M et al.
Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.BMC Cardiovasc Disord. Bd. 6. 2006 S. 44
Oelze, M; Warnholtz, A; Faulhaber, J et al.
NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.Arterioscler Thromb Vasc Biol. Bd. 26. H. 8. 2006 S. 1753-9
Oelze, M; Daiber, A; Brandes, RP et al.
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.Hypertension. Bd. 48. H. 4. 2006 S. 677-84
Schinzel, H
Niedermolekulare Heparine in der IntensivmedizinS. Haas (Hrsg). Niedermolekulare Heparine. Springer 2006
Volz, S; Schinzel, H; Keune, N et al.
Niedermolekulares Heparin bei Fruhgeborenen mit hereditaren Risikofaktoren und venosen Thrombosen.Klin Padiatr. Bd. 218. H. 4. 2006 S. 226-9
Munzel, TF; Post, F
Pathogenese und Therapie des akuten Koronarsyndroms differenzieller Nutzen von GPIIb/IIIa-Rezeptorantagonisten bei Hochrisikopatienten.Dtsch Med Wochenschr. Bd. 131. H. 47 Suppl 7. 2006 S. S215-8
Vollmann, D; Erdogan, A; Himmrich, E et al.
Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.Europace. Bd. 8. H. 5. 2006 S. 371-6
Bierbach, B; Horstick, G; Berg, O et al.
Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.J Thromb Haemost. Bd. 95. H. 2. 2006 S. 354-61